agoya University Pancreatic Tumor Board trial 08

Phase 2

Recruiting

• Conditions: ocally advanced pancreatic cancer

• Registration Number: JPRN-jRCTs041200054
• Lead Sponsor: Kodera Yasuhiro

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-10-22
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

1.Locally advanced pancreatic cancer
2.Age 20<= and <=79
3.Performance status 0-1

Exclusion Criteria

1.distant metastasis
2.severe drug allergy
3.viable multiple primary cancer
4.gastrointestinal invasion
5.apparent infectious status
6.history of abdominal radiotherapy
7.pregnant or breastfeeding female

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
2-year survival rate

Secondary Outcome Measures

Name	Time	Method
Recurrence free survival, overall survival, pathological tumor reduction according to Evans grade, Tumor response defined by RECIST, rate of completion of preoperative therapy, rate of adverse effect, surgical morbidity, early tumor shrinkage, time to treatment failure